The Academy of Managed Care Pharmacy’s Annual Meeting is a meeting of the “pharmacists, payers, providers, and biopharma leaders shaping the future of managed care pharmacy” (AMCP.org). This year, we’re sharing the conference headlines from AMCP Daily Dose, the official daily news briefing for AMCP members that we produce in partnership with AMCP, to bring our readers up to speed on AMCP 2025.  

This year’s meeting highlighted important pharmaceutical marketplace trends, such as rising rates of biosimilar adoption, pharmacy closures creating ‘pharmacy deserts’, supply chain vulnerabilities, and pharmaceutical market growth. Additional noteworthy updates included GLP-1 implications on managed care, federal policy changes impacting pharmacy practices, and AI-driven strategies to optimize specialty drug billing and managing polypharmacy. Read on for the top highlights covered in AMCP Daily Dose! 

Meeting Overview

2025 AMCP Meeting Kicks Off In Houston: Managed Healthcare Executive

Market Trends and Challenges

Speakers At AMCP 2025 Discuss Trends Driving Change In Managed Care: American Journal of Managed Care

Federal Policy Updates and Implications

AMCP 2025 Panelists Discuss How Federal Policy Changes Impact Managed Care Pharmacy: American Journal of Managed Care

Treatment Innovations

Studies Highlight JAK Inhibitors’ Potential As Alternative Treatment For Patients With AD: American Journal of Managed Care

AMCP 2025 Panelists Discuss Other Uses For GLP-1 Drugs: Managed Healthcare Executive

AI and Technology

AI-Driven Strategies Can Optimize Special Drug Billing, Manage Polypharmacy, Research Suggests: American Journal of Managed Care

For more industry insights like this, follow us on LinkedIn and Instagram!